# reload+after+2024-01-21 14:32:16.149444
address1§22 Einstein Street
address2§Floor 4
city§Ness Ziona
zip§7414003
country§Israel
phone§972 7 2394 2377
website§https://www.biomx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
fullTimeEmployees§54
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Jonathan Eitan Solomon MBA', 'age': 46, 'title': 'CEO & Director', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 528568, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marina  Wolfson CPA', 'age': 39, 'title': 'CFO & Secretary', 'yearBorn': 1984, 'fiscalYear': 2022, 'totalPay': 279416, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Merav  Bassan Ph.D.', 'age': 57, 'title': 'Chief Development Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 356586, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Rotem  Sorek Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Eran  Elinav M.D., Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Timothy K. Lu M.D., Ph.D.', 'age': 42, 'title': 'Scientific Founder', 'yearBorn': 1981, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Inbal  Benjamini-Elran', 'title': 'C.H.R.O', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Assaf  Oron', 'age': 49, 'title': 'Chief Business Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 352037, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.258
currency§USD
dateShortInterest§1702598400
exchange§ASE
quoteType§EQUITY
shortName§BiomX Inc.
longName§BiomX Inc.
firstTradeDateEpochUtc§1552483800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§79f496b8-a482-326c-9356-662c9a6d1300
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§1.823
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
